Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals

This publication has 22 references indexed in Scilit:

• Interleukin 4 is localized to and released by human mast cells.
  The Journal of Experimental Medicine, 1992
• Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.
  Journal of Clinical Investigation, 1992
• Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma
  Clinical and Experimental Allergy, 1992
• Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease.
  The Journal of Experimental Medicine, 1992
• Induction of TH1 and TH2 responses: a key role for the ‘natural’ immune response?
  Immunology Today, 1992
• Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.
  Journal of Clinical Investigation, 1991
• Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects.
  The Journal of Experimental Medicine, 1991
• Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.
  The Journal of Experimental Medicine, 1988
• Immune cell populations in cutaneous delayed-type hypersensitivity.
  The Journal of Experimental Medicine, 1983
• Immunohistological analysis of delayed-type hypersensitivity in man
  Cellular Immunology, 1982